THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Michael Gold to Humans

This is a "connection" page, showing publications Michael Gold has written about Humans.
Connection Strength

0.960
  1. Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study. J Low Genit Tract Dis. 2019 Apr; 23(2):110-115.
    View in: PubMed
    Score: 0.037
  2. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. J Low Genit Tract Dis. 2019 Apr; 23(2):87-101.
    View in: PubMed
    Score: 0.037
  3. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. Radiology. 2017 05; 283(2):450-459.
    View in: PubMed
    Score: 0.032
  4. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. J Low Genit Tract Dis. 2013 Jan; 17(1):51-7.
    View in: PubMed
    Score: 0.024
  5. A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jun; 125(3):635-9.
    View in: PubMed
    Score: 0.023
  6. A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer. Gynecol Oncol. 2012 May; 125(2):388-93.
    View in: PubMed
    Score: 0.023
  7. Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment. J Low Genit Tract Dis. 2011 Jan; 15(1):11-4.
    View in: PubMed
    Score: 0.021
  8. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Gynecol Oncol. 2009 Feb; 112(2):337-41.
    View in: PubMed
    Score: 0.018
  9. A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer. Gynecol Oncol. 2008 Oct; 111(1):89-94.
    View in: PubMed
    Score: 0.018
  10. Cervical dysplasia among women over 35 years of age. Am J Obstet Gynecol. 2008 Nov; 199(5):471.e1-5.
    View in: PubMed
    Score: 0.017
  11. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008 May 01; 112(9):1954-63.
    View in: PubMed
    Score: 0.017
  12. PET in cervical cancer--implications for 'staging,' treatment planning, assessment of prognosis, and prediction of response. J Natl Compr Canc Netw. 2008 Jan; 6(1):37-45.
    View in: PubMed
    Score: 0.017
  13. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol. 2007 Dec; 107(3):398-403.
    View in: PubMed
    Score: 0.017
  14. Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am J Obstet Gynecol. 2007 Aug; 197(2):141.e1-6.
    View in: PubMed
    Score: 0.017
  15. A LEEP cervical conization is rarely indicated for a two-step discrepancy. J Low Genit Tract Dis. 2007 Jul; 11(3):134-7.
    View in: PubMed
    Score: 0.016
  16. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007 Sep; 106(3):521-5.
    View in: PubMed
    Score: 0.016
  17. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007 Jun; 105(3):630-4.
    View in: PubMed
    Score: 0.016
  18. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol. 2007 May; 105(2):299-303.
    View in: PubMed
    Score: 0.016
  19. Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone. Gynecol Oncol. 2006 Feb; 100(2):379-84.
    View in: PubMed
    Score: 0.015
  20. A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol. 2005 Oct; 99(1):50-7.
    View in: PubMed
    Score: 0.015
  21. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. Ann Oncol. 2024 Aug; 35(8):728-738.
    View in: PubMed
    Score: 0.013
  22. Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies. Gynecol Oncol. 2003 Aug; 90(2):325-30.
    View in: PubMed
    Score: 0.013
  23. Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol. 2003 Apr; 26(2):171-3.
    View in: PubMed
    Score: 0.012
  24. Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study. Gynecol Oncol. 2023 04; 171:67-75.
    View in: PubMed
    Score: 0.012
  25. Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. Gynecol Oncol. 2023 03; 170:11-18.
    View in: PubMed
    Score: 0.012
  26. New options in contraception for adolescents. Curr Womens Health Rep. 2001 Oct; 1(2):116-23.
    View in: PubMed
    Score: 0.011
  27. Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). J Clin Oncol. 2021 06 10; 39(17):1842-1855.
    View in: PubMed
    Score: 0.011
  28. Factors affecting fellowship satisfaction among gynecologic oncology fellows. Gynecol Oncol. 2001 Jan; 80(1):74-8.
    View in: PubMed
    Score: 0.010
  29. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
    View in: PubMed
    Score: 0.010
  30. Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective. J Low Genit Tract Dis. 2020 Apr; 24(2):184-191.
    View in: PubMed
    Score: 0.010
  31. Cadet basic training: an ethnographic study of stress and coping. Mil Med. 2000 Feb; 165(2):147-52.
    View in: PubMed
    Score: 0.010
  32. Papillary adenocarcinoma of unknown primary in a young woman: a clinicopathologic correlation conference from the University of Oklahoma College of Medicine. J Okla State Med Assoc. 1999 Nov; 92(11):529-34.
    View in: PubMed
    Score: 0.010
  33. Prescribing and managing oral contraceptive pills and emergency contraception for adolescents. Pediatr Clin North Am. 1999 Aug; 46(4):695-718.
    View in: PubMed
    Score: 0.009
  34. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
    View in: PubMed
    Score: 0.009
  35. Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstet Gynecol. 2018 09; 132(3):725-735.
    View in: PubMed
    Score: 0.009
  36. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
    View in: PubMed
    Score: 0.009
  37. Young women's attitudes toward injectable and implantable contraceptives. J Pediatr Adolesc Gynecol. 1998 Feb; 11(1):17-24.
    View in: PubMed
    Score: 0.009
  38. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol. 2017 12; 130(6):1218-1225.
    View in: PubMed
    Score: 0.008
  39. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 04; 287(1):176-184.
    View in: PubMed
    Score: 0.008
  40. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. J Low Genit Tract Dis. 2017 Oct; 21(4):216-222.
    View in: PubMed
    Score: 0.008
  41. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. J Low Genit Tract Dis. 2017 Oct; 21(4):230-234.
    View in: PubMed
    Score: 0.008
  42. Bilateral absence of the ovaries and distal fallopian tubes. A case report. J Reprod Med. 1997 Jun; 42(6):375-7.
    View in: PubMed
    Score: 0.008
  43. A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results. J Low Genit Tract Dis. 2016 Apr; 20(2):119-25.
    View in: PubMed
    Score: 0.008
  44. Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. J Low Genit Tract Dis. 2016 Apr; 20(2):154-61.
    View in: PubMed
    Score: 0.008
  45. A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Gynecol Oncol. 2016 05; 141(2):364-370.
    View in: PubMed
    Score: 0.007
  46. Conversion reactions in adolescents. Pediatr Ann. 1995 Jun; 24(6):296-8, 301-2, 305-6.
    View in: PubMed
    Score: 0.007
  47. Contraception update: implantable and injectable methods. Pediatr Ann. 1995 Apr; 24(4):203-7.
    View in: PubMed
    Score: 0.007
  48. New progestin oral contraceptives and the female condom. Pediatr Ann. 1995 Apr; 24(4):211-6.
    View in: PubMed
    Score: 0.007
  49. Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
    View in: PubMed
    Score: 0.007
  50. Children of gay or lesbian parents. Pediatr Rev. 1994 Sep; 15(9):354-8; quiz 358.
    View in: PubMed
    Score: 0.007
  51. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol. 2014 Sep; 122(9):694-701.
    View in: PubMed
    Score: 0.007
  52. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
    View in: PubMed
    Score: 0.007
  53. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014 Jan; 33(1):64-73.
    View in: PubMed
    Score: 0.006
  54. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan; 52(1):187-92.
    View in: PubMed
    Score: 0.006
  55. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol. 2013 Sep; 130(3):595-600.
    View in: PubMed
    Score: 0.006
  56. We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
    View in: PubMed
    Score: 0.006
  57. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013 May; 208(5):410.e1-6.
    View in: PubMed
    Score: 0.006
  58. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr; 129(1):86-91.
    View in: PubMed
    Score: 0.006
  59. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013 Feb; 128(2):155-9.
    View in: PubMed
    Score: 0.006
  60. Reproducibility of linear array for human papillomavirus genotyping. J Clin Microbiol. 2013 Feb; 51(2):625-8.
    View in: PubMed
    Score: 0.006
  61. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
    View in: PubMed
    Score: 0.006
  62. Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82.
    View in: PubMed
    Score: 0.006
  63. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012 Nov 01; 30(31):3786-91.
    View in: PubMed
    Score: 0.006
  64. Cotyledonoid dissecting leiomyoma of the uterus: a review of clinical, pathological, and radiological features. Int J Surg Pathol. 2012 Aug; 20(4):330-41.
    View in: PubMed
    Score: 0.006
  65. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
    View in: PubMed
    Score: 0.006
  66. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
    View in: PubMed
    Score: 0.006
  67. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer. 2012 Sep 15; 131(6):E946-53.
    View in: PubMed
    Score: 0.006
  68. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol. 2012 May; 50(5):1564-70.
    View in: PubMed
    Score: 0.006
  69. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012; 7(1):e29051.
    View in: PubMed
    Score: 0.006
  70. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology. 2010 Sep; 19(9):955-8.
    View in: PubMed
    Score: 0.005
  71. Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol. 2010 Aug; 203(2):113.e1-6.
    View in: PubMed
    Score: 0.005
  72. Distress in women with gynecologic cancer. Psychooncology. 2010 Jun; 19(6):665-8.
    View in: PubMed
    Score: 0.005
  73. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study. J Pediatr Adolesc Gynecol. 2010 Aug; 23(4):209-14.
    View in: PubMed
    Score: 0.005
  74. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb; 29(2):95-101.
    View in: PubMed
    Score: 0.005
  75. Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. J Clin Oncol. 2010 Mar 01; 28(7):1215-23.
    View in: PubMed
    Score: 0.005
  76. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
    View in: PubMed
    Score: 0.005
  77. Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol. 2009 Dec; 115(3):493-6.
    View in: PubMed
    Score: 0.005
  78. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009 Aug; 114(2):365-9.
    View in: PubMed
    Score: 0.005
  79. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.
    View in: PubMed
    Score: 0.005
  80. Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol. 2009 Jun; 200(6):645.e1-5.
    View in: PubMed
    Score: 0.005
  81. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer. 2009 Feb 15; 124(4):964-9.
    View in: PubMed
    Score: 0.005
  82. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
    View in: PubMed
    Score: 0.005
  83. Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. J Clin Microbiol. 2008 Aug; 46(8):2759-65.
    View in: PubMed
    Score: 0.004
  84. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Jul; 110(1):76-82.
    View in: PubMed
    Score: 0.004
  85. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes. Gynecol Oncol. 2008 Mar; 108(3):466-71.
    View in: PubMed
    Score: 0.004
  86. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Gynecol Oncol. 2008 Feb; 108(2):342-7.
    View in: PubMed
    Score: 0.004
  87. Pathologic findings and outcomes for octogenarians presenting with uterine malignancy. Gynecol Oncol. 2007 Sep; 106(3):572-8.
    View in: PubMed
    Score: 0.004
  88. Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. Gynecol Oncol. 2007 Sep; 106(3):498-501.
    View in: PubMed
    Score: 0.004
  89. Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer. 2007 Jul-Aug; 17(4):886-9.
    View in: PubMed
    Score: 0.004
  90. Carcinosarcoma of the ovary-a case series. Gynecol Oncol. 2006 Jan; 100(1):128-32.
    View in: PubMed
    Score: 0.004
  91. Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol. 2005 Jun; 14(2):59-64.
    View in: PubMed
    Score: 0.004
  92. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Gynecol Oncol. 2004 Oct; 95(1):70-6.
    View in: PubMed
    Score: 0.003
  93. Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. Gynecol Oncol. 2004 Oct; 95(1):157-64.
    View in: PubMed
    Score: 0.003
  94. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol. 2004 Aug; 94(2):249-55.
    View in: PubMed
    Score: 0.003
  95. Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study. Am J Obstet Gynecol. 2004 May; 190(5):1249-57.
    View in: PubMed
    Score: 0.003
  96. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2004 Feb; 103(2):317-26.
    View in: PubMed
    Score: 0.003
  97. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003 Dec; 91(3):470-5.
    View in: PubMed
    Score: 0.003
  98. Outpatient implantation of a central venous access system in gynecologic oncology patients. J Reprod Med. 2003 Nov; 48(11):875-81.
    View in: PubMed
    Score: 0.003
  99. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol. 2003 May; 89(2):295-300.
    View in: PubMed
    Score: 0.003
  100. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol. 2003 Apr; 188(4):916-26.
    View in: PubMed
    Score: 0.003
  101. Pitfalls of radiation survey after brachytherapy implant removal preceding Tl-201 study. Clin Nucl Med. 2002 Jul; 27(7):494-8.
    View in: PubMed
    Score: 0.003
  102. Laparoscopic pelvic and paraaortic lymph node dissection in the obese. Gynecol Oncol. 2002 Mar; 84(3):426-30.
    View in: PubMed
    Score: 0.003
  103. Panniculectomy with simultaneous gynecologic oncology surgery. Gynecol Oncol. 2001 Dec; 83(3):518-22.
    View in: PubMed
    Score: 0.003
  104. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol Oncol. 2001 Dec; 83(3):563-8.
    View in: PubMed
    Score: 0.003
  105. Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001 Nov; 78(3):194-200; discussion 200-1.
    View in: PubMed
    Score: 0.003
  106. Laparoscopic pelvic and paraaortic lymph node dissection: analysis of the first 100 cases. Gynecol Oncol. 2001 Sep; 82(3):498-503.
    View in: PubMed
    Score: 0.003
  107. A retrospective analysis of radical hysterectomies done for cervical cancer: is there a role for the Pfannenstiel incision? Gynecol Oncol. 2001 Jun; 81(3):481-4.
    View in: PubMed
    Score: 0.003
  108. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma. J Natl Cancer Inst. 2001 Apr 04; 93(7):516-25.
    View in: PubMed
    Score: 0.003
  109. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. J Med Chem. 1999 Oct 21; 42(21):4434-45.
    View in: PubMed
    Score: 0.002
  110. Squamous metaplasia of the endometrium associated with HPV 6 and 11. Gynecol Oncol. 1997 Jul; 66(1):141-5.
    View in: PubMed
    Score: 0.002
  111. CAUSES OF PATIENTS' DELAY IN DISEASES OF THE BREAST. Cancer. 1964 May; 17:564-77.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES